Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449949) titled 'A Single-Arm Study on the Efficacy of Sequential Chemoradiotherapy Followed by Surgery in Adult Nasal and Paranasal Sinus Rhabdomyosarcoma' on Feb. 27.

Study Type: Observational

Primary Sponsor: Eye & ENT Hospital of Fudan University

Condition: ORR PFS OS

Intervention: Radiation: VMAT

Recruitment Status: Recruiting

Date of First Enrollment: October 30, 2025

Target Sample Size: 43

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07449949

Disclaimer: Curated by HT Syndication....